Advance the Next Generation of Safe & More Effective Therapies for Bleeding Disorders
Boston, MA
Joined May 2019
- Tweets14
- Following160
- Followers68
- Likes1
"Gene Editing Restores Factor VIII Levels, Eases Bleeding in Mice with Hemophilia A". Find out more here hemophilianewstoday.com/2019…
Olubunmi Afonja, Medical Director, @BayerPharma shares with us the challenges and considerations in medical affairs for novel hemophilia drug development. Find out more here: ter.li/ijpltt
"Experimental gene therapy for hemophilia, developed by Pfizer and Sangamo, shows early promise". Find out more here: statnews.com/2019/07/05/expe…
Last chance for discounted registration for the 2nd Annual @HDDSummit ! Register before Friday, July 12th to save $600. Find out more here: ter.li/qssgpo
Monday's are tough, but Tuesday's can be hard too. To brighten today, we wanted to remind you of our Summit group discount! ter.li/tekwy4 #HDDSummit #HemophiliaDrugDevelopment
Michael Ero, Chief Executive Officer & President, @MachaonDx shares with us the Application of State-of-the-art Laboratory Techniques to an Ever-changing Hemophilia Drug Landscape. Find out more here: ter.li/un2lld
Hemophilia Drug Development retweeted
Children Are Different, and So Are Their Experiences with Hemophilia bionewsfeeds.com/2019/06/19/…
It's nearly the weekend! Take a break and secure your place for #HDDSummit. Register now: ter.li/bw6hcr
"Candidate Cell Therapy Controls Bleeding in Mouse Model of Hemophilia A". Find out more here: hemophilianewstoday.com/2019… #HDDSummit #HemophiliaDrugDevelopment #HemophiliaDD
Sander Van Deventer, Chief Scientific Officer, @uniQure_NV shares with us the Significance of Neutralizing Antibodies in Gene Therapy in Hemophilia. Find out more here: ter.li/dh8pg7
"Ratio Between FVIII and Von Willebrand Factor Predicts Relapse in Patients with Acquired Hemophilia A, Study Reveals". Find out more here: hemophilianewstoday.com/2019… #HDDSummit #HemophiliaDrugDevelopment
Hemophilia Drug Development is coming to Boston on 20-22 August, and this Friday, 7 June is your last chance to benefit from an exclusive $800 discount! Register here: ter.li/9uchjk
Find out more about the ‘Improving Patient Access to Gene Therapy Through Novel Payer and Reimbursement Strategies’ by signing up to Workshop B led by speakers Michelle Rice & Brendan Hayes! Check out other workshop options by clicking here: ter.li/79wdnk
Join the dedicated industry summit addressing challenges in hemophilia treatment! ter.li/1szx19 #HDDSummit #HemophiliaDrugDevelopmentSummit